Trade-offs between benefits and harms of drugs: a stated preference study with adult patients with cancer in Europe (Patient preferences)

03/06/2021
12/06/2024
EU PAS number:
EUPAS41433
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

EMA patient preferences on benefits and harms of cancer drugs_Protocol_v3.0_Clean

English (1.09 MB - PDF) View document
Updated protocol

EMA patient preferences on benefits and harms of cancer drugs_Protocol 6 December 2021

First published: 22/02/2024
English (1.11 MB - PDF) View document
Study results
Study results

EMA patient preferences on benefits and harms of cancer drugs - Final Report v1.0 03May

English (1.72 MB - PDF) View document
Study report
Other information